Halozyme Therapeutics
HALO
#2334
Rank
S$8.61 B
Marketcap
S$69.93
Share price
1.31%
Change (1 day)
1.81%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): S$0.80 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.08 Billion. In 2024 the company made an earning of S$0.71 Billion, an increase over its 2023 earnings that were of S$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.80 B12.31%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.32 B0.16%
2021 S$0.32 B92.2%
2020 S$0.16 B-278.96%
2019 -S$93.14 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$79.42 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.55 Million-52.86%
2014 -S$88.15 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$69.04 Million169.94%
2011 -S$25.58 Million-63.44%
2010 -S$69.95 Million-7.19%
2009 -S$75.36 Million15.91%
2008 -S$65.02 Million83.89%
2007 -S$35.36 Million78.1%
2006 -S$19.86 Million16%
2005 -S$17.12 Million45.24%
2004 -S$11.79 Million682.42%
2003 -S$1.51 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$42.85 M-94.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.53 B 2,148.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.92 Billion-217.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.33 B 1,609.45%๐Ÿ‡บ๐Ÿ‡ธ USA
S$11.31 B 1,351.47%๐Ÿ‡ซ๐Ÿ‡ท France
S$35.33 B 4,430.76%๐Ÿ‡บ๐Ÿ‡ธ USA